Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

ClinicalTrials.gov ID: NCT05369403

Public ClinicalTrials.gov record NCT05369403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.

Study identification

NCT ID
NCT05369403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
86 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2022 (Actual)
Primary completion
Jan 11, 2024 (Actual)
Completion
Feb 5, 2025 (Actual)
Last update posted
Feb 25, 2026

2022 – 2025

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
River Region Dermatology and Laser Montgomery Alabama 36117 —
Medical Dermatology Specialists Phoenix Arizona 85006 —
First OC Dermatology Fountain Valley California 92708 —
Axon Clinical Research Inglewood California 90301 —
Avance Clinical Trials Inc Laguna Niguel California 92677 —
Dermatology Research Associates Los Angeles California 90045 —
Wallace Medical Group, Inc. Los Angeles California 90056 —
Clinical Science Institute Santa Monica California 90404 —
Cura Clinical Research Sherman Oaks California 91403 —
UConn Health Farmington Connecticut 06030-2840 —
Encore Medical Research of Boynton Beach Boynton Beach Florida 33436 —
Total Vein and Skin LLC Boynton Beach Florida 33437 —
Direct Helpers Research Center Hialeah Florida 33012 —
Hollywood Dermatology Hollywood Florida 33021 —
Miami Dermatology and Laser Research Miami Florida 33173 —
Ziaderm Research, LLC. North Miami Beach Florida 33162 —
Olympian Clinical Research Tampa Florida 33615 —
Skin Care Physicians of Georgia Macon Georgia 31217 —
Advanced Medical Research Sandy Springs Georgia 30328 —
Dundee Dermatology West Dundee Illinois 60118 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
Dermatology and Advanced Aesthetics Lake Charles Louisiana 70605 —
Dermatology and Skin Cancer Specialists, LLC Rockville Maryland 20850 —
Allcutis Research, Inc. Beverly Massachusetts 01915 —
Oakland Hills Dermatology Auburn Hills Michigan 48326 —
The Derm Institute of West Michigan Caledonia Michigan 49316 —
Revival Research Institute - Troy Troy Michigan 48084 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Allcutis Research, Inc Portsmouth New Hampshire 03801 —
Windsor Dermatology, P.C. East Windsor New Jersey 08520 —
Sadick Research Group New York New York 10075 —
OptiSkin Medical New York New York 10128 —
Dermatologists of Greater Columbus Bexley Ohio 43209 —
Dermatology and Skin Surgery Center, PC Exton Pennsylvania 19341 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Complete Dermatology Sugar Land Texas 77479 —
Spokane Dermatology Clinic Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05369403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05369403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →